Rapport Therapeutics Appoints Chief People Officer
Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance precision neuromedicines, today announced the appointment of Kathy Wilkinson as Chief People Officer.
- Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance precision neuromedicines, today announced the appointment of Kathy Wilkinson as Chief People Officer.
- “Bringing Kathy on board as our Chief People Officer is tremendously exciting as the Rapport team rapidly expands,” said Abraham Ceesay, Chief Executive Officer of Rapport.
- “Any company’s success requires top talent and a vibrant culture, and Kathy has the experience and vision to ensure that Rapport will incorporate those two crucial ingredients as it advances its programs.
- The 250-person company was spun out from bluebird bio, where Kathy served in a variety of human resource roles – most recently Chief People Officer – for nearly a decade.